Skip to main content
. 2011 Jul 21;64(4):320–324. doi: 10.1016/S0377-1237(08)80009-3

Table 3.

Efficacy comparisons on the final outcome in one year

Outcome Topiramate group (n=38) Naltrexone group (n=26) Acamprosate group (n=28)
Abstinences 29 (76.3%) 15 (57.7%) 17 (60.70%)
Minor lapses 02 (05.3%) 03 (11.5%) 02 (07.20%)
Relapses 07 (18.4%) 08 (30.8%) 09 (32.10%)